Ingenza appoints Steve Jones as its new Chief Financial Officer

pharmafile | April 4, 2023 | Appointment | Business Services Ingenza 


Ingenza appoints Steve Jones as its new Chief Financial Officer


Ingenza is pleased to welcome Steve Jones as he takes on the role of Chief Financial Officer (CFO), effective immediately. Steve has over 25 years of industry experience and know-how, after holding several senior finance roles across a wide range of business sectors, sizes and ownership models, and will use this expertise to help drive Ingenza’s corporate and financial goals.


Steve is a chartered accountant and fellow of the Institute of Chartered Accountants in England and Wales (ICAEW), and runs a successful consultancy business providing financial advice and resources to SMEs to help maximise their growth potential. Steve has extensive experience in the life sciences field, including being the finance director of a private pathology laboratory, where he helped to quickly scale up business operations in response to the demands of the COVID-19 pandemic. He also provides voluntary advice to the Soko Fund, a Scottish charity which aims to improve opportunities for women in Malawi by funding their university education.


Steve commented: “I very much look forward to working closely with the Ingenza team to deliver on its strategic goals and build on the momentum of the company’s already remarkable growth. I have contributed to the success and growth of several SMEs in the life sciences sector, and hope to bring the same positive outcomes to Ingenza in an exciting year of development.” 


Jaymin Amin, Chief Business Officer at Ingenza, added: “Steve’s appointment will allow me to step away from my previous financial and operational responsibilities to focus on accelerating our ambitious new growth strategy, by driving and executing our business development and marketing objectives.”


Dr Ian Fotheringham, Chief Executive Officer at Ingenza, commented: “I am excited to welcome Steve to Ingenza as we continue to build a top executive leadership team with the strategic acumen, operational experience and commercial mindset to deliver a strong high growth strategy and accomplish our prioritized corporate goals.”


For more information, visit




About Ingenza

Ingenza engineers biological systems to make everything from therapeutics to enzymes and consumer products, addressing challenges in human health and the global environment. Ingenza’s understanding of nature, combined with its engineering biology toolbox, allows the company to accelerate customer journeys through key milestones to commercial success. Its scientific and commercial activities are led by a management team with over 60 years’ experience in applied bioscience and the development and commercialisation of bio-based products. In addition to engaging in strategic partnerships to tailor its bioprocess services for clients, the company also licenses its proprietary bioprocess technologies.


Related Content

Green manufacturing from the deep blue sea

UK researchers have embarked on a project to analyse marine microorganisms for enzymes that could …

Latest content